Newsroom
Javier Rivela, Pangaea Oncology CEO, interviewed on Gestiona Radio
Pangaea Oncology listed on the Madrid Stock Exchange
Pangaea Oncology and Laboratorio Echevarne sign an agreement to develop liquid biopsy
More Articles...
- Dr. Rafael Rosell to lead the lung cancer unit at Hospital Quirón Teknon
- Pangaea becomes the first laboratory in Spain to achieve accredition for analysis of genetic mutations in liquid biopsy samples
- Pangaea investigators, co-authors of results presented at ASCO 2016
- Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs